RESTRICTED STOCK UNIT GRANT AGREEMENT JAVELIN PHARMACEUTICALS, INC. 2005 OMNIBUS STOCK INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT
Exhibit (e)(6)(A)
RESTRICTED STOCK UNIT GRANT AGREEMENT
This restricted stock unit agreement (the “Agreement”), dated December 18, 2009 (the “Grant Date”),
is delivered by Javelin Pharmaceuticals, Inc. (the “Company”) to ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ (the
“Grantee”).
1. Grant of Restricted Stock Units. The Company has established an RSU Account on the
Grantee’s behalf under the Javelin Pharmaceuticals, Inc. 2005 Omnibus Stock Incentive Plan (the
“Plan”), and will credit it with ten-thousand (10,000) RSUs upon the Grantee’s signing and
returning to the Company a copy of this Agreement by the deadline specified herein. Unless
otherwise defined herein, capitalized terms used in this Agreement shall have the meaning ascribed
to such terms in the Plan.
2. Nature of Restricted Stock Unit. The RSUs represent an unfunded and unsecured promise
by the Company to deliver Shares in the future in accordance with this Award. The RSUs do not
entitle the Grantee to vote any Shares or to receive dividends. The RSUs may not be transferred,
assigned, hypothecated, pledged, or otherwise encumbered or subjected to any lien, obligation, or
liability of the Grantee.
3. Vesting of the RSUs. Provided that the Grantee remains continuously employed by the
Company or any successor until the applicable vesting date, fifty percent (50%) of the RSUs will
vest on June 17, 2010, and the remaining fifty percent (50%) will vest on June 17, 2011, provided,
however, that upon an earlier Corporate Transaction, all outstanding awards will become fully
vested immediately prior to the consummation of the Corporate Transaction. In the event of the
Grantee’s termination of employment due to death or disability, the RSUs will become fully vested.
Upon termination of the Grantee’s employment for any reason other than death or disability, all of
the Grantee’s then unvested awards will immediately terminate and be forfeited.
4. Payment of the RSUs. Upon the Grantee’s satisfaction of the applicable vesting
conditions, the Company will, in the event of a Corporate Transaction, in advance of the
consummation of the Corporate Transaction, and in all other events, within thirty (30) business
days, distribute a Share to the Grantee for each RSU credited to the Grantee’s RSU Account.
5. No Implied Rights. Nothing contained in this Agreement or in the Plan shall confer upon
the Grantee any right with respect to the terms of or continuation of the Grantee’s employment with
the Company, or to interfere with the right of the Company to terminate the Grantee’s employment at
any time, with or without cause.
1
6. Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of Delaware, without regard to conflict of laws provisions.
7. Taxes. The Company does not make any representation to the Grantee, by way of this
Agreement or otherwise, with respect to the tax consequences of the RSUs granted or any subsequent
disposition of the Shares acquired under the RSUs. The Grantee agrees to pay the Company in cash
or to make appropriate arrangements with the Company for the satisfaction of all federal, state,
local, and foreign income and employment tax withholding requirements applicable to the RSUs. The
Grantee acknowledges and agrees that his or her rights under this Agreement are subject to his or
her payment of all taxes under this Paragraph 7.
8. Code Section 83(b). The Grantee acknowledges that the crediting of RSUs to the
Grantee’s RSU Account does not constitute a transfer of property to which an election under Section
83(b) of the Internal Revenue Code would apply and that, accordingly, the Grantee cannot choose to
be taxed upon grant of the RSUs.
9. Release of Claims. In exchange for the grant of RSUs provided under this Agreement, to
which the Grantee would not otherwise be entitled, the Grantee agrees that this Agreement shall be
in complete and final settlement of any and all causes of action, rights or claims that the Grantee
may have had in the past, now has, or might now have, in any way related to, connected with or
arising out of the amendment and restatement of the Plan approved by the Company’s Board of
Directors on December 18, 2009 pursuant to any federal, state or local law, regulation or other
requirement and you hereby release and forever discharge the Company its Affiliates, the Plan
administrators and all of their respective past and present directors, shareholders, officers,
employees, agents and representatives, their successors and assigns, and all others connected with
any of them, both individually and in their official capacities, from any and all such causes of
action, rights and claims.
10. Agreement Subject to Plan. This Agreement is made pursuant to the Plan, the terms of
which are incorporated herein by reference, and in all respects shall be interpreted in accordance
with the Plan. In the event of a conflict between the terms and conditions of the Plan and this
Agreement, the terms and conditions of the Plan shall prevail. In the event of any ambiguity in
this Agreement or any matters as to which this Agreement is silent, the Plan shall govern
including, without limitation, the provisions thereof pursuant to which the Committee has the
power, among others, to (i) interpret the Plan and Awards related thereto, (ii) prescribe, amend
and rescind rules and regulations relating to the Plan, and (iii) make all other determinations
deemed necessary or advisable for the administration of the Plan. Its determination shall be
conclusive and binding upon the Grantee, and shall be given the maximum deference permitted by law.
The Grantee acknowledges by signing this Agreement that he or she has received and reviewed a copy
of the Plan and any prospectus that has been prepared with respect to the Plan.
11. Entire Agreement. This Agreement and the Plan constitute the entire agreement between
the Company and the Grantee with respect to the RSUs granted herein.
2
12. Assurances. In signing this Agreement, the Grantee gives the Company assurance that he
or she has signed it voluntarily and with a full understanding of its terms; that the Grantee has
had sufficient opportunity to consider this Agreement; and that, in signing this Agreement, the
Grantee has not relied on any promises or representations, express or implied, that are not set
forth expressly in this Agreement.
If the foregoing is acceptable to the Grantee, please sign, date and return a copy of this
Agreement to ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ by March 9, 2010.
| JAVELIN PHARMACEUTICALS, INC. | ||||||
| By: | /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ | |||||
[The remainder of this page has been left blank intentionally.]
3
The undersigned hereby acknowledges receipt of the foregoing Agreement, a copy of the Plan, and a
copy of any prospectus that has been prepared with respect to the Plan, and agrees to be bound by
all of the terms and conditions of each with respect to the RSUs granted herein.
GRANTEE:
Signature:
|
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ | |||
Print Name:
|
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ |
4